🇺🇸 FDA
Patent

US 11389566

Method and composition for treating inflammatory bowel disease

granted A61KA61K35/22A61K35/38

Quick answer

US patent 11389566 (Method and composition for treating inflammatory bowel disease) held by Regentys Corporation expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regentys Corporation
Grant date
Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K35/22, A61K35/38, A61P, A61P1/00